Your browser doesn't support javascript.
loading
Differential Serum-intestinal Dynamics of Infliximab and Adalimumab in Inflammatory Bowel Disease Patients.
Bar-Yoseph, Haggai; Blatt, Alexandra; Gerassy, Shiran; Pressman, Sigal; Mousa, Amjad; Sabo, Edmond; Waterman, Matti; Ungar, Bella; Ben-Horin, Shomron; Chowers, Yehuda.
Afiliação
  • Bar-Yoseph H; Department of Gastroenterology, Rambam Health Care Campus, Haifa, Israel.
  • Blatt A; Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.
  • Gerassy S; Department of Gastroenterology, Rambam Health Care Campus, Haifa, Israel.
  • Pressman S; Department of Gastroenterology, Rambam Health Care Campus, Haifa, Israel.
  • Mousa A; Department of Gastroenterology, Rambam Health Care Campus, Haifa, Israel.
  • Sabo E; Department of Internal Medicine H, Rambam Health Care Campus, Haifa, Israel.
  • Waterman M; Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.
  • Ungar B; Department of Pathology, Carmel Medical Center, Haifa, Israel.
  • Ben-Horin S; Department of Gastroenterology, Rambam Health Care Campus, Haifa, Israel.
  • Chowers Y; Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel.
J Crohns Colitis ; 16(6): 884-892, 2022 Jul 14.
Article em En | MEDLINE | ID: mdl-34849649
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Inibidores do Fator de Necrose Tumoral Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Inibidores do Fator de Necrose Tumoral Idioma: En Ano de publicação: 2022 Tipo de documento: Article